Abstract
This work aims at describing the wide variety of questions relative to the treatment of locally advanced non-small cell lung cancer; it shows how the advent of new results induces new questions, as well as the diversity of clinical research directions. Lung cancer represents a model of organization of multimodal therapeutic algorithms, the ultimate aim being the therapeutic optimization of the most frequent cancer.
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Carcinoma, Non-Small-Cell Lung / drug therapy*
-
Carcinoma, Non-Small-Cell Lung / radiotherapy*
-
Combined Modality Therapy / methods
-
Humans
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / radiotherapy*
-
Meta-Analysis as Topic
-
Neoadjuvant Therapy
-
Radiation-Sensitizing Agents / therapeutic use
-
Radiotherapy, Conformal
Substances
-
Radiation-Sensitizing Agents